Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination
BioLineRX Ltd.: BioLineRx Announces FDA Approval of APHEXDA ...
BioLineRx initiates Phase 2 first-line metastatic pancreatic cancer ...
BioLineRx & Ayrmid Ink Exclusive License Agreement to Commercialize ...
BLRX | BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 ...
BioLineRx Ltd. (BLRX) Stock Price, Quote, News & Analysis | Seeking Alpha
BioLineRx on LinkedIn: #bioeurope
BioLineRx today announced the initiation of a randomized, investigator ...
BioLineRx Announces New Positive Results In Phase 2a Trial For Orally ...
BioLineRx | Discover Our Pipeline
Biolinerx hi-res stock photography and images - Alamy
BioLineRx & GenFleet Co-Development — MSQ
BioLineRx Sees Surge: Time to Invest?
BioLineRx logo
BioLineRx Announces New Positive Results in Phase 2a trial for Orally ...
BioLineRx | Discover Careers
BioLineRx (BLRX)’s APHEXDA Captures 10% Market Share in U.S. CXCR4 ...
Almac and BioLineRx Partner for APHEXDA® Launch in the US - PharmaSource
BioLineRx reveals FDA approval for APHEXDA™ (motixafortide) to ...
BioLineRx Unveils Poster Presentation on Economic Model Data for ...
BioLineRx | Driving innovative therapeutics across the finish line
BioLineRx (BLRX) Stock Price & Overview
BL-8020 exclusive License Agreement with BioLineRx – Genoscience Pharma
BioLineRx Announces Publication of Pre-clinical Results Demonstrating ...
BioLineRx Stock: On a Path to Growth?
BioLineRx Ltd. (BLRX) BCG Matrix Analysis – DCFmodeling.com
BioLineRx on LinkedIn: We are proud to announce collaboration agreement ...
BioLineRx (BLRX) Stock Price, News & Analysis
BL-8030 worldwide License Agreement with BioLineRx – Genoscience Pharma
BioLineRx | LinkedIn
BioLineRx | Contact Us
BioLineRx lance « Mobilization Matters » : Une ressource numérique pour ...
Israel’s BioLineRx progresses in clinical trials of treatment relevant ...
BioLineRx | Partner with Us
BioLineRx Launches JV With Hemispherian - IsraelDesks
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma ...
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a ...
BioLineRx ($BLRX) is excited to announce strengthening of its ...
BioLineRx BLRX Q2 2025 Earnings Preview Upside Potential Amid ...
BioLineRx Reports Q3 2025 Results and Strategic Expansion
BioLineRx stem cell drug for myeloma patients wins FDA nod - Globes
BioLineRx to Report 2024 Annual Results on March 31, 2025 ...
BioLineRx Realigns Strategy, Pipeline Focus Fuels Future Growth ...
BioLineRx Ltd. (BLRX): Business Model Canvas – DCFmodeling.com
#biolinerx #meetourteam #clinicaloperations | BioLineRx
#tandem24 | BioLineRx
BioLineRx on LinkedIn: #jpm2024 #fiercejpmweek
BioLineRx Receives Orphan Drug Designation for Novel Stem Cell ...
BioLineRx | F6S
FDA Approves BioLineRx Drug for Multiple Myeloma – ISPE Boston
BioLineRx | Learn About BioLineRx
BioLineRx Ltd. - AnnualReports.com
BioLineRx - Alchetron, The Free Social Encyclopedia
BioLineRx Logo im transparenten PNG- und vektorisierten SVG-Format
BioLineRx Ltd. - ROE
BioLineRx Ltd. (BLRX) ANSOFF Matrix Analysis – DCFmodeling.com
BioLineRx closes license deal for motixafortide in Asia | The Pharmaletter
Irit Gliko-Kabir - VP, Clinical Operations at BioLineRx | The Org
BLRX | BioLineRX Ltd Stock Data, Price & News
BioLineRx ($BLRX) is excited to announce that the first patient has ...
BioLineRX Receives $8M Investment
BioLineRx | Modi`in
BioLineRx - Company Profile, Photos, and Jobs on Project Casting - 8421
BLRX Stock Price and Chart — NASDAQ:BLRX — TradingView
We’re proud to announce FDA Approval of an innovative treatment to ...
BioLineRx: Advancing Oncology Solutions | PDF | Hematopoietic Stem Cell ...
BioLineRx's Q3 2025 Financial Disclosure and Corporate Strategy ...
We are excited to bring innovation to patients with multiple myeloma ...
BioLineRX’s BL-7010 Treatment of Celiac Disease and Gluten Sensitivity ...
BioLineRx社の末梢血への造血幹細胞誘導薬Aphexdaを米国FDAが承認 | せいみ屋
快讯 | BioLineRx多发性骨髓瘤环肽新药获FDA批准上市 - 知乎
BioLineRx’s Aphexda approved to aid stem cell transplants for multiple ...
BioLineRx's Q1 2025: Unpacking Contradictions in Cash Runway ...
BioLineRx's Pancreatic Cancer Breakthrough: Motixafortide's PFS Data ...
#fdaapproval #aphexda #medicalinnovation #multiplemyeloma #biolinerx ...
BioLineRx's proof-of-concept study is an initial step towards the goal ...
We are pleased to have served as the Exclusive Placement Agent for ...
BioLineRx's Motixafortide Combination Therapy: A Paradigm Shift in ...
Companies Financial Statements
Portfolio | Giza Venture Capital
Host Companies | Project Onramp
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China ...
Aphexda-Aphexda中文说明书,价格,哪里有卖-香港济民药业
劲方医药与BioLineRx达成合作，共同加速开发CXCR4抑制剂motixafortide医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Israeli Tech and Innovation News - NoCamels
Biolinerx’s stem cell mobilizer approved for MM patients | BioWorld
